文献速递心脑血管急症重症综合管理与镇静镇痛

入院时N末端脑钠肽前体水平升高可预测普通外科重症监护患者新发房颤

Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论普通外科与创伤ICU患者入院NT-proBNP≥600 ng/L、年龄>70岁、既往房颤史是术后3天内新发房颤的独立预测因素。

该研究纳入2015年7月至10月间387例普通外科与创伤ICU患者,入院时均无房颤,检测入院NT-proBNP并按年龄校正界值判定异常。结果发现NT-proBNP异常者新发房颤风险为22%,正常者为4%(p<0.0001)。按最佳界值分层,NT-proBNP<600 ng/L者房颤风险2%,600-1999 ng/L者15%,≥2000 ng/L者27%。多因素回归显示年龄>70岁(OR 3.7)、既往房颤史(OR 25.3)、NT-proBNP≥600 ng/L(OR 4.3)为独立预测因素;三者均无或仅一项时房颤发生率<1%,三者齐备时达66%。

要点

  • 入院NT-proBNP异常(年龄校正界值)者新发房颤风险22%,正常者4%(p<0.0001)。
  • NT-proBNP<600 ng/L者房颤风险2%,600-1999 ng/L者15%,≥2000 ng/L者27%。
  • 独立预测因素:年龄>70岁(OR 3.7,95%CI 1.5-9.3)、既往房颤史(OR 25.3,95%CI 9.6-67.0)、NT-proBNP≥600 ng/L(OR 4.3,95%CI 1.3-14.2)。
  • 无或仅一项预测因素时房颤发生率<1%,三项齐备时达66%。
  • 年龄≥70岁无房颤史者,NT-proBNP≥600 ng/L时房颤发生率12.8%,<600 ng/L时为0%。

适用人群与场景

  • 普通外科与创伤ICU患者,入院时无房颤,年龄中位数63岁(52-73岁),女性占40.3%。

诊断标准与关键阈值

  • NT-proBNP异常定义为年龄校正界值。
  • 最佳界值(不考虑年龄):<600 ng/L、600-1999 ng/L、≥2000 ng/L。

研究设计与关键结果

  • 研究类型为队列研究,纳入387例普通外科与创伤ICU患者,入院时均无房颤。
  • 主要结果:NT-proBNP异常者新发房颤风险22%,正常者4%(p<0.0001)。
  • 按最佳界值分层房颤风险:<600 ng/L为2%,600-1999 ng/L为15%,≥2000 ng/L为27%。
  • 多因素logistic回归独立预测因素:年龄>70岁(OR 3.7,95%CI 1.5-9.3)、既往房颤史(OR 25.3,95%CI 9.6-67.0)、NT-proBNP≥600 ng/L(OR 4.3,95%CI 1.3-14.2)。
  • 无或仅一项预测因素时房颤发生率<1%,三项齐备时房颤发生率66%。
  • 年龄≥70岁无房颤史者,NT-proBNP≥600 ng/L时房颤发生率12.8%,<600 ng/L时为0%。
  • 年龄<70岁有房颤史者,NT-proBNP≥600 ng/L时房颤发生率44.4%,<600 ng/L时为0%。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,将NT-proBNP测量加入已知危险因素可提高预测能力,并识别可能从循证预防性房颤治疗中获益的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: New onset atrial fibrillation (AF) in critically ill surgical patients is associated with significant morbidity and increased mortality. N-terminal pro-B type natriuretic peptide (NT-proBNP) is released by cardiomyocytes in response to stress and may predict AF development after surgery. We hypothesized that elevated NT-proBNP level at surgical intensive care unit (ICU) admission predicts AF development in a general surgical and trauma population.

METHODS: From July to October 2015, NT-proBNP concentrations were measured at ICU admission. Abnormal NT-proBNP concentrations were defined by age-adjusted cut-offs. We examined the relationship between the development of AF and demographics, clinical variables, and NT-proBNP level using univariate analysis and a multivariable logistic regression model.

RESULTS: Three hundred eighty-seven subjects were included in the cohort, none of whom were in AF at ICU admission. The median age was 63 years (52-73 years), and 40.3% were women. The risk of developing AF was higher for abnormal versus normal NT-proBNP (22% vs. 4%; p < 0.0001). Using optimal derived cutoffs (regardless of age), the risk of developing AF was 2% for NT-proBNP less than 600 ng/L, 15% for NT-proBNP of 600 ng/L to 1,999 ng/L, and 27% for NT-proBNP of 2,000 ng/L or greater. Multiple logistic regression analysis identified three independent predictors for new-onset AF: age, older than 70 years (odds ratio [OR], 3.7, 95% confidence interval [CI], 1.5-9.3), history of AF (OR, 25.3; 95% CI, 9.6-67.0), and NT-proBNP of 600 or greater (OR, 4.3; 95% CI, 1.3-14.2). When none or only one predictor was present, AF incidence was less than 1%. When all three predictors were present, AF incidence was 66%. For subjects 70 years or older but no history of AF, AF incidence was 12.8% when NT-proBNP was 600 or greater compared with 0% when NT-proBNP was less than 600. For subjects younger than 70 years with a history of AF, AF incidence was 44.4% when NT-proBNP was 600 or higher compared to 0% when NT-proBNP was less than 600.

CONCLUSION: Elevated NT-proBNP at ICU admission in general surgical and trauma patients is predictive of AF development in the first 3 ICU days. Addition of NT-proBNP measurement to known risk factors can improve predictive power and identify patients who might potentially benefit from evidence-based prophylactic treatment for AF.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Chokengarmwong N, Yeh DD, Chang Y, et al. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients. J Trauma Acute Care Surg. 2017. PMID: 28463935. doi:10.1097/TA.0000000000001552

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。